Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapamycin with Preoperative Radiotherapy in Operable Rectum Cancer
NCT00409994Phase 2Completed
- Sponsor
- Maastro Clinic
- Start
- Sep 2006
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sirolimus in rectal cancer, sponsored by Maastro Clinic. Primary endpoints: Incidence of severe postoperative complications (grade IV or grade V) and Tumour blood flow assessed CT-PET + CTp at day 64. Started Sep 2006; status: completed.
02
Drugs
sirolimus
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT00409994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00409994.